Long-Term Health: Solid Tumor Risk and Prevention

While many families initially focus on blood counts, the long-term health journey in Fanconi anemia (FA) also involves managing a significantly increased risk of certain cancers. Because children with FA have a “broken” DNA repair system, their cells are more likely to develop mutations that lead to solid tumors ^[1]. These risks are manageable through proactive, lifelong surveillance, but they require a shift in how you and your care team monitor your child’s health as they grow.

The Specific Risks of Solid Tumors

The most common solid tumors in FA are a type called Squamous Cell Carcinoma (SCC). These cancers typically appear in the “lining” tissues of the body ^[2].

• Head and Neck: This is the most frequent site, particularly the oral cavity (mouth and tongue) ^[3]. The absolute risk of these cancers is significantly elevated compared to the general population ^[4].
• Anogenital Region: This includes the vulva, vagina, cervix, penis, and anus ^[2][5].
• Esophagus: The tube connecting the throat to the stomach is another area that requires monitoring, particularly as patients reach adulthood ^[6].

The Age Timeline

While the risk of solid tumors is very low in early childhood, it increases as the body accumulates DNA damage over time ^[7]. Estimates vary by cohort, but risk rises substantially as patients enter young adulthood. This is why screening becomes more intensive as your child enters adolescence.

The “Transplant Paradox”

It is a common misunderstanding that a stem cell transplant (HSCT) “cures” the risk of cancer. While HSCT is the definitive treatment for the marrow, it actually increases the risk of solid tumors later in life ^[5][8].

• Persistent Risk: The transplant only replaces blood-forming cells. The rest of the body’s cells (in the mouth, throat, and skin) still have the FA repair defect ^[9].
• Conditioning Factors: Exposure to radiation or certain chemotherapy drugs during the transplant process, along with chronic graft-versus-host disease, can further stress the DNA, potentially leading to tumors ^[10][11].
• Late-Onset Risks: In studies of transplant survivors, the risk of head and neck cancer rises significantly in the years after the procedure ^[12]. Lifelong surveillance is mandatory for every transplant survivor.

Your Screening Roadmap

Specialist-guided screening schedules catch any changes at their earliest, most treatable stage. The schedule must be tailored to your child’s age, anatomy, and transplant history.

Head, Neck, and Oral Screening

• When to Start: Specialized screening often begins by age 10, or after a stem cell transplant ^[4].
• Frequency: Typically every 6 months ^[13].
• The Exam: An FA-experienced specialist (such as an ENT or oral surgeon) should perform a thorough visual and physical exam of the mouth, throat, and neck ^[13].

The “Persistent Lesion” Rule

This is an important guideline for parents to remember: Contact the FA/oral specialist promptly for any oral sore, white or red patch (leukoplakia or erythroplakia), or ulcer that persists for approximately two weeks ^[13]. Do not wait for a fixed deadline if the lesion looks worrisome (e.g., painful, enlarging, bleeding). An automatic biopsy is not required for every lesion; the examining clinician will decide if observation, treatment for infection, or a biopsy is most appropriate.

Anogenital, Gynecological, and Skin Screening

• When to Start: Anatomy- and age-based screening (including exams for the cervix, vulva, vagina, penis, and anus) should be directed by your specialist team, taking into account HPV exposure and transplant history ^[14].
• Frequency: Follow your specialist’s individualized recommendations. Skin should also be monitored regularly for any persistent changes.

Preventive Steps and Risk Reduction

While you cannot eliminate the risk of FA-associated cancers entirely, several practical measures add vital layers of protection:

The HPV Vaccine

The Human Papillomavirus (HPV) is a common virus that can cause many cancers seen in FA, including cervical, anal, and some head and neck cancers ^[15].

• Recommendation: Non-live HPV vaccination is important. The schedule (often two or three doses) depends on the age at first dose and immune status ^[14].
• Post-Transplant: If your child had a transplant, the vaccine series will likely need to be repeated because the new immune system does not “remember” the previous shots ^[14].
• Benefit: While the vaccine is a crucial preventative step, it does not prevent all FA-related cancers and does not replace the need for physical surveillance ^[16].

Additional Risk Reduction

• Avoid Tobacco and Alcohol: Strictly avoid tobacco, vaping, and areca/betel products, and limit alcohol later in life, as these dramatically increase oral cancer risks.
• Dental Health: Maintain excellent dental hygiene to prevent chronic inflammation.
• Sun Protection: Follow specialist advice for sun and skin protection.